A constitutively active pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1548, Issue 1, 2001, Pages 139-151

  Cao, Yong Jiang ^a   Gimpl, Gerald ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Glycosylation; Mutation; Peptide hormone receptor; Photoaffinity labeling; Pituitary adenylate cyclase activating polypeptide

Indexed keywords

AMINO ACID; CARBOHYDRATE; G PROTEIN COUPLED RECEPTOR; GLUTAMINE; HORMONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; IODINE 125; LYSINE; MUTANT PROTEIN; PEPTIDE DERIVATIVE; RECEPTOR SUBTYPE; TUNICAMYCIN; TYROSINE;

ALPHA HELIX; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN; CELL SURFACE; CONTROLLED STUDY; DEGLYCOSYLATION; GENETIC TRANSFECTION; HORMONE RECEPTOR INTERACTION; MOLECULAR WEIGHT; MUTATION; NONHUMAN; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; AFFINITY LABELS; AMIDOHYDROLASES; ANIMALS; COS CELLS; GLYCOSYLATION; MOLECULAR WEIGHT; MUTATION; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PLASMIDS; RATS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE;

EID: 0035832920     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(01)00227-8     Document Type: Article

References (43)

1. Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase activating polypeptide in the ovine hypothalamus
2. Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes
3. PACAP functions as a neurotrophic factor
4. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: Neuroendocrine and endocrine interaction
5. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
6. Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions
7. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
8. Differential signal transduction by five splice variants of the PACAP receptor
9. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP)
10. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
11. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
12. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide
13. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
14. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells
15. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein linked receptor family
16. The amino-terminal fragment of the pituitary adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain
17. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation
18. Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination
19. A mutation of second intracellular loop of pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation
20. Photoaffinity labeling analysis of pituitary adenylate cyclase activating polypeptide (PACAP) interaction with the PACAP type I receptor
21. Identification of binding domains of pituitary adenylate cyclase activating polypeptide (PACAP) for its type I receptor by photoaffinity labeling
22. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
23. Molecular structure analysis of the pituitary adenylate cyclase activating polypeptide type I receptor from pig brain
24. PACAP analogues for identification of the receptor binding site
25. Pituitary adenylyl cyclase-activating peptide activates multiple intracellular signaling pathways to regulate ion channels in PC12 cells
26. 2+ concentration in porcine somatotropes through common and distinct mechanisms
27. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating polypeptide) in membranes from the rat pancreatic acinar cell line AR 4-2J
28. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP)
29. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain
30. Binding sites of pituitary adenylate cyclase activating polypeptide in human brain
31. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK
32. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane
33. G protein-coupled receptors II. Mechanism of agonist activation
34. Structural instability of a constitutively active G protein-coupled receptor
35. The role of N-glycans in the secretory pathway
36. Why mammalian cell surface proteins are glycoproteins
37. Functional glycosylation sites of the rat luteinizing hormone receptor required for ligand binding
38. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function
39. Glycosylation is important for binding to human calcitonin receptors
40. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function
41. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
42. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness
43. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia